France industrial production index: pharmaceuticals (CF)
France industrial production index: pharmaceuticals (CF) stood at 121.07 in Aug 2026, according to INSEE – Institut national de la statistique et des études économiques (BDM). It is one of the indicators in the Industrial production and turnover table (Value · Monthly), with a complete series running from Jan 1990 to Aug 2026. The complete series with an interactive chart, free to download.
This indicator in the Industrial production and turnover table
| Indicator | 08-2026 | 07-2026 | 06-2026 | 05-2026 | 04-2026 | 03-2026 | 02-2026 | 01-2026 | 12-2025 | 11-2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Manufacture of basic pharmaceutical products and pharmaceutical preparations (NAF rev. 2, level A38, item CF) | 121.07 | 122.84 | 120.9 | 121.24 | 116.81 | 118.96 | 116.41 | 115.14 | 119.78 | 113.55 | |
| Manufacture of rubber and plastics products, and other non-metallic mineral products (NAF rev. 2, level A38, item CG) | 82.02 | 84.17 | 85.32 | 85.97 | 87.31 | 86.67 | 84.43 | 86.68 | 86.67 | 85.66 | |
| Manufacture of basic metals and fabricated metal products, except machinery and equipment (NAF rev. 2, level A38, item CH) | 89.97 | 89.88 | 91.11 | 91.35 | 92.03 | 91.65 | 91.03 | 91.39 | 91.77 | 89.78 |
Understanding france industrial production index: pharmaceuticals (CF)
Measuring the industrial output of medicinal chemicals, biological products, diagnostic preparations, and finished pharmaceutical dosage forms, this series isolates the healthcare manufacturing branch. It excludes retail pharmacy operations, medical device fabrication, and basic chemical synthesis not intended for therapeutic use. This sector displays strong defensive characteristics, showing independence from macroeconomic downturns due to non-discretionary healthcare demand and long-term demographic trends.
Interpreting this pharmaceutical output index requires accounting for lumpy batch production cycles of specialized vaccines or advanced biological therapeutics that can distort monthly comparisons. Revisions can occur as manufacturers update compliance and output data for regulated medical products. Observers must avoid mixing this specialized metric with general chemical manufacturing, as pharmaceutical demand drivers and cost structures differ entirely from bulk chemical commodities.
Frequently asked questions
- What exact products are included in this pharmaceutical manufacturing index?
- Medicinal active ingredients, prescription drugs, vaccines, diagnostic substances, and finished pharmaceutical preparations.
- Why does this sector typically resist broader economic recession cycles?
- Demand for medications and healthcare products is driven by medical needs rather than consumer discretionary income.
- How do batch production schedules influence monthly figures in this industry?
- Large-scale manufacturing runs of specific vaccines or biologics can cause sharp monthly production jumps followed by normalization.